Sevoflurane, Propofol, Postoperative Pain
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01437462|
Recruitment Status : Completed
First Posted : September 21, 2011
Last Update Posted : April 10, 2013
|Condition or disease||Intervention/treatment||Phase|
|Healthy Adults Gynecological Disease||Drug: Sevoflurane Drug: Propofol||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||168 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Postoperative Pain After Propofol Sevoflurane Anaesthesia: a Prospective, Randomized, Single-blinded Trial|
|Study Start Date :||October 2008|
|Actual Primary Completion Date :||March 2013|
|Actual Study Completion Date :||March 2013|
- Postoperative consumption of an opioid (oxycodone) [ Time Frame: 20 hours ]The consumption of oxycodone will be monitored by recording the amount of the drug received via a commercially available patient controlled analgesia (PCA) pump.
- NRS (numeral rating scale) of pain [ Time Frame: 20 hours ]NRS is evaluated frequently during the study period.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01437462
|Tampere University Hospital|
|Tampere, Finland, 33521|